(Q46438925)

22 December 2017

title

Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat. (English)

1 reference

22 December 2017

1

Adeleke M Badejo

1 reference

22 December 2017

Philip J. Kadowitz

6

object named as

Philip J Kadowitz

1 reference

22 December 2017

author name string

Jasdeep S Dhaliwal

2

1 reference

22 December 2017

David B Casey

3

1 reference

22 December 2017

Thomas B Gallen

4

1 reference

22 December 2017

Anthony J Greco

5

1 reference

22 December 2017

publication date

8 August 2008

1 reference

22 December 2017

American Journal of Physiology - Lung Cellular and Molecular Physiology

published in

1 reference

22 December 2017

volume

295

1 reference

22 December 2017

issue

5

1 reference

22 December 2017

page(s)

L828-36

1 reference

22 December 2017

Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Regulation and functions of Rho-associated kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Protein kinase A in complex with Rho-kinase inhibitors Y-27632, Fasudil, and H-1152P: structural basis of selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Chronic hypoxia induces Rho kinase-dependent myogenic tone in small pulmonary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Targeting Rho and Rho-kinase in the treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Characterization of thromboxane receptor blocking effects of SQ 29548 in the feline pulmonary vascular bed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Angiotensin II signal transduction through small GTP-binding proteins: mechanism and significance in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

ROCKs as therapeutic targets in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Ca2+ signaling in hypoxic pulmonary vasoconstriction: effects of myosin light chain and Rho kinase antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPLUNG.00042.2008

10.1152/AJPLUNG.00042.2008

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017